A61K47/52

SUPERPARAMAGNETISM-MODIFIED AND NEUTROPHIL EXOSOME BIOMIMETIC VESICLE-BASED BIOLOGICAL PREPARATION FOR DRUG DELIVERY, AND PREPARATION METHOD THEREOF

The present disclosure provides a superparamagnetism-modified and neutrophil exosome biomimetic vesicle-based biological preparation for drug delivery, and a preparation method thereof, belonging to the technical field of engineered nanovesicle drug loading systems. The superparamagnetism-modified and neutrophil exosome biomimetic vesicle-based biological preparation for drug delivery prepared by the preparation method acts on tumor cell lines. It is found that the superparamagnetism-modified and neutrophil exosome biomimetic vesicle-based biological preparation for drug delivery can specifically target tumor cells, induce tumor cell apoptosis, and inhibit tumor growth. The biological preparation significantly extends a survival time of mice and improves an efficacy of drugs against cancers.

SUPERPARAMAGNETISM-MODIFIED AND NEUTROPHIL EXOSOME BIOMIMETIC VESICLE-BASED BIOLOGICAL PREPARATION FOR DRUG DELIVERY, AND PREPARATION METHOD THEREOF

The present disclosure provides a superparamagnetism-modified and neutrophil exosome biomimetic vesicle-based biological preparation for drug delivery, and a preparation method thereof, belonging to the technical field of engineered nanovesicle drug loading systems. The superparamagnetism-modified and neutrophil exosome biomimetic vesicle-based biological preparation for drug delivery prepared by the preparation method acts on tumor cell lines. It is found that the superparamagnetism-modified and neutrophil exosome biomimetic vesicle-based biological preparation for drug delivery can specifically target tumor cells, induce tumor cell apoptosis, and inhibit tumor growth. The biological preparation significantly extends a survival time of mice and improves an efficacy of drugs against cancers.

High load dispersions

The present invention relates to the field of carrier and delivery systems for active molecular compounds. In particular, the present invention provides aqueous dispersions for delivery of active molecular compounds.

High load dispersions

The present invention relates to the field of carrier and delivery systems for active molecular compounds. In particular, the present invention provides aqueous dispersions for delivery of active molecular compounds.

NANOCOMPOSITES OF NITROGEN-DOPED GRAPHENE OXIDE AND MANGANESE OXIDE FOR PHOTODYNAMIC THERAPY AND MAGNETIC RESONANCE IMAGING

The present invention relates to a NDG-Mn.sub.3O.sub.4 nanocomposite comprising a nitrogen doped graphene (NDG) and Mn.sub.3O.sub.4 nanoparticles. The NDG-Mn.sub.3O.sub.4 nanocomposite is useful in bimodal performance including photodynamic therapy (PDT) and magnetic resonance imaging (MRI). The NDG-Mn.sub.3O.sub.4 nanocomposites of the present invention caused significant cell death under laser irradiation, while control and Mn.sub.3O.sub.4 nanoparticles showed negligible cell death.

NANOCOMPOSITES OF NITROGEN-DOPED GRAPHENE OXIDE AND MANGANESE OXIDE FOR PHOTODYNAMIC THERAPY AND MAGNETIC RESONANCE IMAGING

The present invention relates to a NDG-Mn.sub.3O.sub.4 nanocomposite comprising a nitrogen doped graphene (NDG) and Mn.sub.3O.sub.4 nanoparticles. The NDG-Mn.sub.3O.sub.4 nanocomposite is useful in bimodal performance including photodynamic therapy (PDT) and magnetic resonance imaging (MRI). The NDG-Mn.sub.3O.sub.4 nanocomposites of the present invention caused significant cell death under laser irradiation, while control and Mn.sub.3O.sub.4 nanoparticles showed negligible cell death.

Tolerogenic synthetic nanocarriers

This invention relates, at least in part, to compositions comprising synthetic nanocarriers and immunosuppressants that result in immune suppressive effects. Such compositions can further comprise antigen and provide antigen-specific tolerogenic immune responses.

Tolerogenic synthetic nanocarriers

This invention relates, at least in part, to compositions comprising synthetic nanocarriers and immunosuppressants that result in immune suppressive effects. Such compositions can further comprise antigen and provide antigen-specific tolerogenic immune responses.

Magnetic particle conjugates, micelles, and methods of delivering agents

Embodiments of the present disclosure provide for magnetic particle conjugates, methods of making the magnetic particle conjugates, methods of using magnetic particle conjugates, micelles (also referred to as a “magnetic composite nanocarrier” (MCNC)), methods of making micelles, methods of using micelles, and the like.

Magnetic particle conjugates, micelles, and methods of delivering agents

Embodiments of the present disclosure provide for magnetic particle conjugates, methods of making the magnetic particle conjugates, methods of using magnetic particle conjugates, micelles (also referred to as a “magnetic composite nanocarrier” (MCNC)), methods of making micelles, methods of using micelles, and the like.